Rankl antibody-pth/pthrp chimeric molecules

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/28 (2006.01) A01K 67/027 (2006.01) A61K 39/395 (2006.01) A61P 19/10 (2006.01) C07K 14/635 (2006.01) C07K 14/705 (2006.01) C07K 19/00 (2006.01)

Patent

CA 2628628

Chimeric molecules comprising receptor activator of NF-kB ligand (RANKL) antibodies and parathyroid hormone/parathyroid hormone-related protein (PTH/PTHrP) peptides are described. Compositions and methods for the treatment of bone diseases are also described.

La présente invention concerne des molécules chimères comprenant un activateur du récepteur d~un anticorps du ligand NF-kB (RANKL) et des peptides de l~hormone parathyroïdienne/de la protéine apparentée à l~hormone parathyroïdienne (PTH/PTHrP). Des compositions et procédés pour le traitement de maladies osseuses sont également décrits.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Rankl antibody-pth/pthrp chimeric molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Rankl antibody-pth/pthrp chimeric molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rankl antibody-pth/pthrp chimeric molecules will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1383953

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.